AVIAT NETWORKS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AVIAT NETWORKS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Jun 28, 2019 | $64.23M | Aug 27, 2019 |
| FY2019 | Mar 29, 2019 | $54.04M | Aug 27, 2019 |
| FY2019 | Dec 28, 2018 | $65.09M | Aug 27, 2019 |
| FY2019 | Sep 28, 2018 | $60.50M | Aug 27, 2019 |
| FY2019 | Jun 29, 2018 | $62.51M | Aug 27, 2019 |
| FY2019 | Mar 30, 2018 | $62.09M | Aug 27, 2019 |
| FY2019 | Dec 29, 2017 | $61.72M | Aug 27, 2019 |
| FY2019 | Sep 29, 2017 | $56.18M | Aug 27, 2019 |
| FY2018 | Jun 30, 2017 | $56.43M | Aug 28, 2018 |
| FY2018 | Mar 31, 2017 | $58.70M | Aug 28, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jul 2, 2021 | $71.69M | Aug 25, 2021 |
| FY2021 | Apr 2, 2021 | $66.40M | Aug 25, 2021 |
| FY2021 | Jan 1, 2021 | $70.53M | Aug 25, 2021 |
| FY2021 | Oct 2, 2020 | $66.29M | Aug 25, 2021 |
| FY2021 | Jul 3, 2020 | $62.65M | Aug 25, 2021 |
| FY2021 | Apr 3, 2020 | $61.38M | Aug 25, 2021 |
| FY2021 | Dec 27, 2019 | $56.00M | Aug 25, 2021 |
| FY2021 | Sep 27, 2019 | $58.61M | Aug 25, 2021 |
| FY2020 | Jun 28, 2019 | $64.23M | Aug 27, 2020 |
| FY2020 | Mar 29, 2019 | $54.04M | Aug 27, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $56.43M | Sep 6, 2017 |
| FY2017 | Mar 31, 2017 | $58.70M | Sep 6, 2017 |
| FY2017 | Dec 30, 2016 | $68.54M | Sep 6, 2017 |
| FY2017 | Sep 30, 2016 | $58.21M | Sep 6, 2017 |
| FY2017 | Jul 1, 2016 | $58.25M | Sep 6, 2017 |
| FY2017 | Apr 1, 2016 | $60.47M | Sep 6, 2017 |
| FY2017 | Jan 1, 2016 | $70.42M | Sep 6, 2017 |
| FY2017 | Oct 2, 2015 | $79.56M | Sep 6, 2017 |
| FY2016 | Jul 3, 2015 | $87.73M | Sep 9, 2016 |
| FY2016 | Apr 3, 2015 | $74.84M | Sep 9, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $139.44M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $144.73M | Sep 10, 2025 |
| FY2025 | Jun 30, 2023 | $122.38M | Sep 10, 2025 |
| FY2024 | Jul 1, 2022 | $109.24M | Oct 4, 2024 |
| FY2021 | Jul 2, 2021 | $25.88M | Aug 25, 2021 |
| FY2021 | Apr 2, 2021 | $25.58M | Aug 25, 2021 |
| FY2021 | Jan 1, 2021 | $26.91M | Aug 25, 2021 |
| FY2021 | Oct 2, 2020 | $24.25M | Aug 25, 2021 |
| FY2021 | Jul 3, 2020 | $21.86M | Aug 25, 2021 |
| FY2021 | Apr 3, 2020 | $21.96M | Aug 25, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $1.34M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $10.76M | Sep 10, 2025 |
| FY2025 | Jun 30, 2023 | $10.17M | Sep 10, 2025 |
| FY2024 | Jul 1, 2022 | $21.16M | Oct 4, 2024 |
| FY2021 | Jul 2, 2021 | $2.83M | Aug 25, 2021 |
| FY2021 | Apr 2, 2021 | $94.73M | Aug 25, 2021 |
| FY2021 | Jan 1, 2021 | $6.64M | Aug 25, 2021 |
| FY2021 | Oct 2, 2020 | $5.94M | Aug 25, 2021 |
| FY2021 | Jul 3, 2020 | $1.14M | Aug 25, 2021 |
| FY2021 | Apr 3, 2020 | $731.0K | Aug 25, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $10.58M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $19.40M | Sep 10, 2025 |
| FY2025 | Jun 30, 2023 | $24.62M | Sep 10, 2025 |
| FY2024 | Jul 1, 2022 | $28.75M | Oct 4, 2024 |
| FY2021 | Jul 2, 2021 | $3.73M | Aug 25, 2021 |
| FY2021 | Apr 2, 2021 | $4.04M | Aug 25, 2021 |
| FY2021 | Jan 1, 2021 | $7.88M | Aug 25, 2021 |
| FY2021 | Oct 2, 2020 | $6.57M | Aug 25, 2021 |
| FY2021 | Jul 3, 2020 | $2.12M | Aug 25, 2021 |
| FY2021 | Apr 3, 2020 | $1.24M | Aug 25, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $35.77M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $36.43M | Sep 10, 2025 |
| FY2025 | Jun 30, 2023 | $24.91M | Sep 10, 2025 |
| FY2024 | Jul 1, 2022 | $22.60M | Oct 4, 2024 |
| FY2023 | Jul 2, 2021 | $21.81M | Aug 30, 2023 |
| FY2022 | Jul 3, 2020 | $19.28M | Sep 14, 2022 |
| FY2021 | Jun 28, 2019 | $21.11M | Aug 25, 2021 |
| FY2020 | Jun 29, 2018 | $19.75M | Aug 27, 2020 |
| FY2019 | Jun 30, 2017 | $18.68M | Aug 27, 2019 |
| FY2018 | Jul 1, 2016 | $20.81M | Aug 28, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $89.48M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $85.04M | Sep 10, 2025 |
| FY2025 | Jun 30, 2023 | $69.84M | Sep 10, 2025 |
| FY2024 | Jul 1, 2022 | $57.66M | Oct 4, 2024 |
| FY2023 | Jul 2, 2021 | $56.32M | Aug 30, 2023 |
| FY2022 | Jul 3, 2020 | $57.99M | Sep 14, 2022 |
| FY2021 | Jun 28, 2019 | $56.06M | Aug 25, 2021 |
| FY2020 | Jun 29, 2018 | $58.16M | Aug 27, 2020 |
| FY2019 | Jun 30, 2017 | $57.18M | Aug 27, 2019 |
| FY2018 | Jul 1, 2016 | $65.90M | Aug 28, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $5.72M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $30.54M | Sep 10, 2025 |
| FY2025 | Jun 30, 2023 | ($1.64M) | Sep 10, 2025 |
| FY2024 | Jul 1, 2022 | $2.79M | Oct 4, 2024 |
| FY2023 | Jul 2, 2021 | $17.30M | Aug 30, 2023 |
| FY2022 | Jul 3, 2020 | $17.49M | Sep 14, 2022 |
| FY2021 | Jun 28, 2019 | $2.94M | Aug 25, 2021 |
| FY2020 | Jun 29, 2018 | $8.21M | Aug 27, 2020 |
| FY2019 | Jun 30, 2017 | $9.41M | Aug 27, 2019 |
| FY2018 | Jul 1, 2016 | $356.0K | Aug 28, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $12.97M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $2.68M | Sep 10, 2025 |
| FY2025 | Jun 30, 2023 | $5.34M | Sep 10, 2025 |
| FY2024 | Jul 1, 2022 | $1.79M | Oct 4, 2024 |
| FY2023 | Jul 2, 2021 | $2.85M | Aug 30, 2023 |
| FY2022 | Jul 3, 2020 | $4.61M | Sep 14, 2022 |
| FY2021 | Jun 28, 2019 | $5.25M | Aug 25, 2021 |
| FY2020 | Jun 29, 2018 | $6.56M | Aug 27, 2020 |
| FY2019 | Jun 30, 2017 | $4.02M | Aug 27, 2019 |
| FY2018 | Jul 1, 2016 | $1.57M | Aug 28, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $633.30M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $535.22M | Sep 10, 2025 |
| FY2024 | Jun 30, 2023 | $363.14M | Oct 4, 2024 |
| FY2023 | Jul 1, 2022 | $323.90M | Aug 30, 2023 |
| FY2022 | Jul 2, 2021 | $297.65M | Sep 14, 2022 |
| FY2021 | Jul 3, 2020 | $179.80M | Aug 25, 2021 |
| FY2020 | Jun 28, 2019 | $169.19M | Aug 27, 2020 |
| FY2019 | Jun 29, 2018 | $156.06M | Aug 27, 2019 |
| FY2018 | Jun 30, 2017 | $152.58M | Aug 28, 2018 |
| FY2017 | Jul 1, 2016 | $166.11M | Sep 6, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $370.11M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $279.34M | Sep 10, 2025 |
| FY2024 | Jun 30, 2023 | $144.40M | Oct 4, 2024 |
| FY2023 | Jul 1, 2022 | $122.15M | Aug 30, 2023 |
| FY2022 | Jul 2, 2021 | $114.32M | Sep 14, 2022 |
| FY2021 | Jul 3, 2020 | $111.12M | Aug 25, 2021 |
| FY2020 | Jun 28, 2019 | $97.68M | Aug 27, 2020 |
| FY2019 | Jun 29, 2018 | $98.55M | Aug 27, 2019 |
| FY2018 | Jun 30, 2017 | $98.24M | Aug 28, 2018 |
| FY2017 | Jul 1, 2016 | $112.65M | Sep 6, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $263.18M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $255.89M | Sep 10, 2025 |
| FY2025 | Jun 30, 2023 | $218.74M | Sep 10, 2025 |
| FY2025 | Jul 2, 2022 | $201.75M | Sep 10, 2025 |
| FY2024 | Jul 1, 2022 | $201.75M | Oct 4, 2024 |
| FY2024 | Jul 2, 2021 | $183.34M | Oct 4, 2024 |
| FY2023 | Jul 3, 2020 | $68.68M | Aug 30, 2023 |
| FY2022 | Jun 28, 2019 | $71.52M | Sep 14, 2022 |
| FY2018 | Jun 29, 2018 | $57.52M | Aug 28, 2018 |
| FY2018 | Jun 30, 2017 | $53.80M | Aug 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $19.66M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $8.22M | Sep 10, 2025 |
| FY2024 | Jun 30, 2023 | $5.11M | Oct 4, 2024 |
| FY2023 | Jul 1, 2022 | $0 | Aug 30, 2023 |
| FY2014 | Jun 27, 2014 | $0 | Dec 22, 2014 |
| FY2014 | Jun 28, 2013 | $0 | Dec 22, 2014 |
| FY2013 | Jun 29, 2012 | $0 | Sep 23, 2013 |
| FY2012 | Jul 1, 2011 | $5.60M | Sep 4, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | ($577.17M) | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | ($578.51M) | Sep 10, 2025 |
| FY2024 | Jun 30, 2023 | ($589.27M) | Oct 4, 2024 |
| FY2023 | Jul 1, 2022 | ($599.44M) | Aug 30, 2023 |
| FY2022 | Jul 2, 2021 | ($620.60M) | Sep 14, 2022 |
| FY2021 | Jul 3, 2020 | ($730.74M) | Aug 25, 2021 |
| FY2020 | Jun 28, 2019 | ($731.00M) | Aug 27, 2020 |
| FY2020 | Jun 30, 2018 | ($740.74M) | Aug 27, 2020 |
| FY2019 | Jun 29, 2018 | ($746.36M) | Aug 27, 2019 |
| FY2018 | Jun 30, 2017 | ($748.20M) | Aug 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $59.69M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | $64.62M | Sep 10, 2025 |
| FY2024 | Jun 30, 2023 | $22.24M | Oct 4, 2024 |
| FY2023 | Jul 1, 2022 | $36.88M | Aug 30, 2023 |
| FY2022 | Jul 2, 2021 | $47.94M | Sep 14, 2022 |
| FY2021 | Jul 3, 2020 | $41.62M | Aug 25, 2021 |
| FY2020 | Jun 28, 2019 | $31.95M | Aug 27, 2020 |
| FY2019 | Jun 29, 2018 | $37.43M | Aug 27, 2019 |
| FY2018 | Jun 30, 2017 | $35.66M | Aug 28, 2018 |
| FY2017 | Jul 1, 2016 | $30.48M | Sep 6, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | $87.59M | Sep 10, 2025 |
| FY2024 | Jun 28, 2024 | $48.35M | Oct 4, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | 0 | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | 0 | Sep 10, 2025 |
| FY2025 | Jun 30, 2023 | 0 | Sep 10, 2025 |
| FY2024 | Jul 1, 2022 | 1 | Oct 4, 2024 |
| FY2021 | Jul 2, 2021 | 0 | Aug 25, 2021 |
| FY2021 | Apr 2, 2021 | 8 | Aug 25, 2021 |
| FY2021 | Jan 1, 2021 | 0 | Aug 25, 2021 |
| FY2021 | Oct 2, 2020 | 0 | Aug 25, 2021 |
| FY2021 | Jul 3, 2020 | 0 | Aug 25, 2021 |
| FY2021 | Apr 3, 2020 | 0 | Aug 25, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | 0 | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | 0 | Sep 10, 2025 |
| FY2025 | Jun 30, 2023 | 0 | Sep 10, 2025 |
| FY2024 | Jul 1, 2022 | 1 | Oct 4, 2024 |
| FY2021 | Jul 2, 2021 | 0 | Aug 25, 2021 |
| FY2021 | Apr 2, 2021 | 8 | Aug 25, 2021 |
| FY2021 | Jan 1, 2021 | 0 | Aug 25, 2021 |
| FY2021 | Oct 2, 2020 | 0 | Aug 25, 2021 |
| FY2021 | Jul 3, 2020 | 0 | Aug 25, 2021 |
| FY2021 | Apr 3, 2020 | 0 | Aug 25, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 27, 2025 | 12.70M | Sep 10, 2025 |
| FY2025 | Jun 28, 2024 | 12.60M | Sep 10, 2025 |
| FY2024 | Jun 30, 2023 | 11.50M | Oct 4, 2024 |
| FY2023 | Jul 1, 2022 | 11.20M | Aug 30, 2023 |
| FY2022 | Jul 2, 2021 | 11.15M | Sep 14, 2022 |
| FY2021 | Jul 3, 2020 | 10.80M | Aug 25, 2021 |
| FY2020 | Jun 28, 2019 | 5.36M | Aug 27, 2020 |
| FY2019 | Jun 29, 2018 | 5.35M | Aug 27, 2019 |
| FY2018 | Jun 30, 2017 | 5.32M | Aug 28, 2018 |
| FY2017 | Jul 1, 2016 | 5.26M | Sep 6, 2017 |